is rybelsus a glp 1 PharmGems Oral GLP-1 receptor agonist Rybelsus

In a study by Klausen et al., exenatide was administered at a dose of 2 mg subcutaneously once weekly for 26 weeks

The product information available through the EMA states that the visceral abnormalities and major skeletal malformations seen after maternal exposure to semaglutide are probably due to embryotoxicity caused by a GLP-1 receptor-mediated impairment of the nutrient supply across the rat yolk sac, which has unclear translational significance for humans due to a difference in yolk sac anatomy

5.2 Safety evaluation In both clinical trials and real-world settings, tirzepatide has demonstrated a favorable safety and tolerability profile

The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)

Not after patent loss